GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jianmin Pharmaceutical Group Co Ltd (SHSE:600976) » Definitions » Sale Of Investment

Jianmin Pharmaceutical Group Co (SHSE:600976) Sale Of Investment : ¥125 Mil (TTM As of Sep. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Jianmin Pharmaceutical Group Co Sale Of Investment?

Jianmin Pharmaceutical Group Co's sale of investment for the three months ended in Sep. 2024 was ¥102 Mil. It means Jianmin Pharmaceutical Group Co gained ¥102 Mil from selling investments. Jianmin Pharmaceutical Group Co's sale of investment for the trailing twelve months (TTM) ended in Sep. 2024 was ¥125 Mil.

Compared with last quarter (¥17 Mil in Jun. 2024 ), Jianmin Pharmaceutical Group Co gained more money from selling investments in Sep. 2024 (¥102 Mil).


Jianmin Pharmaceutical Group Co Sale Of Investment Historical Data

The historical data trend for Jianmin Pharmaceutical Group Co's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jianmin Pharmaceutical Group Co Sale Of Investment Chart

Jianmin Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.77 79.71 36.30 183.80 107.54

Jianmin Pharmaceutical Group Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.35 3.76 2.33 16.79 101.86

Jianmin Pharmaceutical Group Co Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥125 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jianmin Pharmaceutical Group Co Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Jianmin Pharmaceutical Group Co's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Jianmin Pharmaceutical Group Co Business Description

Traded in Other Exchanges
N/A
Address
No. 484 Parrot Avenue, Hanyang District, Wuhan, CHN, 430052
Jianmin Pharmaceutical Group Co Ltd is engaged in the manufacture and distribution of pharmaceutical products. It adheres to the core position of pediatric medicine, gynecological medicine, and special Chinese medicine, it offers products under Jianmin and Longmu brands.
Executives
Du Ming De Director
He Qin Director
Gao Kai senior management
Wang Jun senior management
Huang Zhi Jun senior management
Pei Xue Jun senior management
Bu Zhong Jiang Director
Cheng Chao Yang senior management
Xu Sheng senior management
Hu Zhen Bo senior management
Liu Qin Qiang Director
Xiong Fu Liang senior management
Liu Peng senior management

Jianmin Pharmaceutical Group Co Headlines

No Headlines